Tech Company Financing Transactions
EyeCyte Funding Round
EyeCyte closed a $3 million Series A financing round on 6/23/2008. Backers included Pfizer Venture Investments.
Transaction Overview
Company Name
Announced On
6/23/2008
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Pfizer Venture Investments (Corey Goodman)
Proceeds Purpose
The financing will fund the company into 2010 and will be primarily used to drive product development of the company's initial clinical target, diabetic retinopathy.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3366 North Torrey Pines Court 130
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
EyeCyte, Inc., an early stage ophthalmology research and development company based in La Jolla, California, announced that it has secured its seed funding through an agreement with Pfizer. The financing will fund the company to drive product development of the company's initial clinical target, diabetic retinopathy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mohammad El-Kalay
VP - R & D
Matthew Ritter
Browse more venture capital transactions:
Prev: 6/21/2008: Neotropix venture capital transaction
Next: 6/23/2008: AlterG venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs